Medicare Enrolled

Dr. John Gomez, MD

Rheumatology · Humble, TX
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
18955 N MEMORIAL DR STE 77338, Humble, TX 77338
8325304159
In practice since 2005 (20 years)
NPI: 1710970199 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Gomez from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gomez? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Gomez

Dr. John Gomez is a rheumatology specialist in Humble, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Gomez performed 850 Medicare services across 408 unique beneficiaries.

Between the years covered by Open Payments, Dr. Gomez received a total of $8,793 from 40 pharmaceutical and/or device companies across 458 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Gomez is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ 850 Medicare services $8,793 industry payments

Medicare Practice Summary

Medicare Utilization ↗
850
Medicare services
Bottom 42% in TX for rheumatology
408
Unique beneficiaries
$79
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~42 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
457 $87 $449
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
85 $67 $493
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
80 $104 $472
Additional hour of intravenous chemotherapy
This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period.
65 $22 $101
Steroid injection (triamcinolone)
A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered.
57 $1 $17
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
52 $120 $1,056
Joint injection, major joint
Removal of fluid from a large joint and/or injection of medication into the joint space.
22 $60 $320
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
20 $145 $862
New patient office visit, complex (60-74 min) 12 $163 $1,282
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
9.4% high complexity
16.9% medium
73.6% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$8,793
Total received (2018-2024)
Avg $1,256/year across 7 years
Top 36% in TX for rheumatology
40
Companies
458
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,776 (99.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$16 (0.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,352
2023
$2,496
2022
$1,516
2021
$1,280
2020
$1,075
2019
$657
2018
$416

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$2,293
ABBVIE INC.
$1,057
Horizon Therapeutics plc
$758
PFIZER INC.
$670
GlaxoSmithKline, LLC.
$583
AbbVie Inc.
$486
Janssen Biotech, Inc.
$468
UCB, Inc.
$414
Lilly USA, LLC
$270
AstraZeneca Pharmaceuticals LP
$191
Alexion Pharmaceuticals, Inc.
$171
Novartis Pharmaceuticals Corporation
$140
Shionogi Inc
$132
Aurinia Pharma U.S., Inc.
$128
Kiniksa Pharmaceuticals, Ltd.
$110
Boehringer Ingelheim Pharmaceuticals, Inc.
$101
Biogen, Inc.
$74
Sandoz Inc.
$61
Paratek Pharmaceuticals, Inc.
$59
Horizon Pharma plc
$59
AbbVie, Inc.
$58
Mallinckrodt Hospital Products Inc.
$54
Mylan Institutional Inc.
$49
SCILEX PHARMACEUTICALS INC.
$41
Radius Health, Inc.
$41
West-Ward Pharmaceuticals
$39
IDORSIA PHARMACEUTICALS US INC
$38
E.R. Squibb & Sons, L.L.C.
$30
Vyera Pharmaceuticals, LLC
$23
United Therapeutics Corporation
$21
Biocon Biologics Inc
$20
ANI Pharmaceuticals, Inc.
$20
Ultragenyx Pharmaceutical Inc.
$20
Hikma Pharmaceuticals USA
$19
Teva Pharmaceuticals USA, Inc.
$19
Lundbeck LLC
$17
Celltrion USA Inc.
$16
Fidia Pharma USA Inc.
$16
Integra LifeSciences Corporation
$14
ViiV Healthcare Company
$11
Top 3 companies account for 46.7% of total payments
Associated products mentioned in payments ›
ACTHAR · AVSOLA · AVYCAZ · Arcalyst · BENLYSTA · Bimzelx · COSENTYX · CYLTEZO · Cimzia · DALVANCE · DOVATO · DUEXIS · Daraprim 30 Tablet in 1 Bottle · EVENITY · Enbrel · Fetroja · HUMIRA · HYMOVIS · HYRIMOZ · Hulio · Humira · INFLECTRA · KRYSTEXXA · LUPKYNIS · Mitigare · NUZYRA · OFEV · OMNIGRAFT · ONFI · ORENCIA · PENNSAID · PURIFIED CORTROPHIN GEL · QUVIVIQ · RAYOS · REMICADE · RINVOQ · Rinvoq · SAPHNELO · SIMPONI · SIMPONI ARIA · SKYRIZI · STRENSIQ · Strensiq · TALTZ · TAVNEOS · TECFIDERA · TEPEZZA · TREMFYA · TYVASO · Tavneos · Truxima · Tymlos · ULTOMIRIS · VIMOVO · XELJANZ · XTANDI · YUFLYMA · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $1,034 per 100 Medicare services performed
Looking for a rheumatology specialist in Humble?
Compare rheumatologists in the Humble area by procedure volume, costs, and industry payment transparency.
Browse rheumatologists nearby

Geographic Context

Rheumatologists within 10 mi
76
Per 100K population
1.6
County median income
$73,104
Nearest hospital
MEMORIAL HERMANN NORTHEAST HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Gomez is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 20 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Gomez experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Gomez performed 457 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Gomez receive payments from pharmaceutical companies?
Yes. Dr. Gomez received a total of $8,793 from 40 companies across 458 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gomez's costs compare to other rheumatologists in Humble?
Dr. Gomez's average Medicare payment per service is $79. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gomez) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →